NUPR1 and lung adenocarcinoma: Meanwhile, pan-cancer analysis based on the TIMER2 database41 (http://timer.cistrome.org) showed that NUPR1 had an inconsistent expression trend in different tumors, the expression of NUPR1 was decreased in bladder cancer, colon cancer, lung adenocarcinoma, prostate cancer, and other tumors.